Opendata, web and dolomites

COCLICAN SIGNED

COllaborative Consortium for the early detection of LIver CANcer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 COCLICAN project word cloud

Explore the words cloud of the COCLICAN project. It provides you a very rough idea of what is the project "COCLICAN" about.

peru    makers    virus    reinforce    predictive    students    hbv    laos    detected    designed    prognosis    scientific    care    affordable    expertise    continents    policy    biological    etiologic    except    death    countries    innovation    populations    initiation    hbc    levels    anticipate    network    hcc    patients    sustainable    thanks    underserved    material    academic    diagnostic    south    molecules    participate    world    delineate    tackle    improvement    skills    mobilised    construction    technologies    collaborations    left    rate    carcinoma    emergence    profiles    infected    critical    tumour    america    performance    oncoming    stethoscope    capacities    tumorogenesis    proposes    cancer    clinically    discriminant    metabolomics    exchange    smartphone    agents    liver    hepatocellular    asia    tools    burden    health    bunch    connected    gathered    mortality    engineers    hcv    public    detection    global    source    poor    hepatitis    echo    cohort    decades    coclican    issue    lacking    clinicians    serum   

Project "COCLICAN" data sheet

The following table provides information about the project.

Coordinator
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT 

Organization address
address: BOULEVARD DE DUNKERQUE 44 CS 90009
city: MARSEILLE
postcode: 13572
website: www.ird.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 450˙800 €
 EC max contribution 450˙800 € (100%)
 Programme 1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
 Code Call H2020-MSCA-RISE-2018
 Funding Scheme MSCA-RISE
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT FR (MARSEILLE) coordinator 174˙800.00
2    UNIVERSITE PAUL SABATIER TOULOUSE III FR (TOULOUSE CEDEX 9) participant 96˙600.00
3    FONDATION MERIEUX FR (LYON) participant 55˙200.00
4    UNIVERSITE LIBRE DE BRUXELLES BE (BRUXELLES) participant 55˙200.00
5    ASSISTANCE PUBLIQUE HOPITAUX DE PARIS FR (PARIS) participant 36˙800.00
6    KAUNO TECHNOLOGIJOS UNIVERSITETAS LT (KAUNAS) participant 32˙200.00
7    INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-INEN PE (LIMA) partner 0.00
8    MINISTRY OF HEALTH LA (LAO) partner 0.00

Map

 Project objective

Hepatitis B (HBV) and C virus (HCV) are the most important etiologic agents of Hepatocellular carcinoma (HCC), which is the second leading cause of tumour related death in the world. The burden of HCC in developing countries represents a major challenge in global public health for the oncoming decades. Clinically, HCC patients have a very poor prognosis and high 5-year mortality rate except when detected early. As a result, HCC early detection is a critical parameter to anticipate the initiation of a tumour process, but affordable and discriminant diagnostic tools are lacking. A consortium of European and Third Countries institutions (Peru and Laos) gathered within the project COCLICAN proposes to tackle this issue through the analysis of metabolomics serum profiles of a large cohort of HBV-HBC infected patients to delineate a bunch of molecules predictive of the emergence of liver cancer. The performance of a low-cost and open-source echo-stethoscope connected to a smartphone will also be assessed, to allow early detection of tumorogenesis in health care underserved areas. This will be possible, thanks to the construction of a sustainable scientific and academic network of engineers, researchers and clinicians mobilised to exchange expertise, skills, technologies, biological material, deployed in three continents: Europe, South America and Asia. COCLICAN has been designed to improve research collaborations, to reinforce capacities, to enhance knowledge of partners and students involved in the project, but also to raise awareness of policy makers and to participate to the innovation potential improvement at the European and global levels. COCLICAN will therefore respond to the health needs of left behind populations, all around the world.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "COCLICAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "COCLICAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.3.)

MEGA (2019)

Heavy metal free emitters for new-generation light sources

Read More  

VIDEC (2020)

Visualizing Death Inducing Protein Complexes

Read More  

OPEN (2019)

Outcomes of Patients’ Evidence With Novel, Do-It-Yourself Artificial Pancreas Technology

Read More